Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range

MUTLU N., Turkeri L. N., YENCİLEK F., Demir A., Emerk K.

CANADIAN JOURNAL OF UROLOGY, cilt.16, sa.2, ss.4558-4567, 2009 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 2
  • Basım Tarihi: 2009
  • Dergi Adı: CANADIAN JOURNAL OF UROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.4558-4567
  • Marmara Üniversitesi Adresli: Evet

Özet

Background: Data on utilizing complexed prostate specific antigen (cPSA) offering increased diagnostic performance over other available clinical parameters in diagnosis of prostate cancer is still controversial. Our objective was to determine diagnostic performance of cPSA compared to total prostate specific antigen (tPSA) mid corresponding ratios for possible routine application.